release

Yakima Chief Hops Launches Latest Pink Boots Blend, Strengthening Education and Gender Diversity in Fermentation

YAKIMA, Wash., Dec. 9, 2025 /PRNewswire/ -- Yakima Chief Hops (YCH) in partnership with the Pink Boots Society (PBS), is…

2 months ago

NOTICE TO DISREGARD — ICARO Media Group

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- We are advised by ICARO that certain information is subject to confidentiality agreements.…

2 months ago

Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product…

2 months ago

KPM Analytics Enhances NIR Analyzers with New Ready-to-Use NIR Calibration Packages to Simplify Food & Feed Quality Analysis

SpectraStar™ XT Series Users Now Have Easier Access to KPM's Extensive Calibration Library for Confident Quality AssuranceWESTBOROUGH, Mass., Dec. 4,…

2 months ago

Ascent Cloud Announces Winter 2026 Release of its Sales Performance Management Solutions

DETROIT, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ascent Cloud has announced the Winter 2026 Release of its industry-leading Sales Performance…

2 months ago

Casio to Release 25 Design Calculators

Delivering Joy with Plenty of Color and Style ChoicesTOKYO, Dec. 1, 2025 /PRNewswire/ -- Casio Computer Co., Ltd. announced the…

3 months ago

Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program

November 28, 2025 20:13 ET  | Source: Rakovina Therapeutics Inc VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina…

3 months ago

The GameFi-cation of Trading: Fortuva Announces New Update Blurring the Line Between Markets and Gaming

TAMPA, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Fortuva today announced a significant update to its on-chain, high-frequency prediction market…

3 months ago

Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…

3 months ago

Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…

3 months ago